Background: There is a body of evidence to suggest that cigarette smoking increases the risk of cervical cancer in women, but no study has examined the magnitude of the association in Japanese women. Here, we evaluated the association between cigarette smoking and the risk of cervical cancer in Japanese women based on a systematic review of epidemiological evidence. Methods: Original data were obtained from a MEDLINE search using PubMed or from a search of the 'Ichushi' database, as well as by a manual search. Evaluation of associations was based on the strength of evidence and the magnitude of association, together with biological plausibility as evaluated previously by the International Agency for Research on Cancer. Meta-analysis of associations was also conducted to obtain a summarized overview of the data. Results: We identified two cohort studies and three case-control studies. All five studies had indicated strong positive associations between cigarette smoking and the risk of cervical cancer. Our summary estimate indicated that the relative risk (RR) for individuals who had ever-smoked relative to never-smokers was 2.03 (95% confidence interval: 1.49-2.57). Four studies had also demonstrated dose-response relationships between cigarette smoking and the risk of cervical cancer.
Introduction
Cancer of the uterine cervix is a common gynecological cancer with a higher incidence in developing countries than in developed countries such as Japan (1, 2) . In Japan, cancer of the uterine cervix is one of the most common cancer in women; 11 000 new cases were diagnosed in 2011, and~2900 cases were ultimately fatal in 2014 (3). In Japan over the last few decades, both the incidence of cervical cancer and the associated mortality rate have been increasing in the last 10 years (3-5). Between 1999 and 2013, the age-standardized incidence rate of cervical cancer for Japanese women actually increased from 9.0 to 13.8, peak in women in their 40s-50s, and increasing in younger women in their 20s and 30s (3).
Cigarette smoking is a well-known major risk factor for cancer. The most recent evaluation by the International Agency for Research on Cancer (IARC) placed cigarette smoking in Group 1, i.e., carcinogenic to humans (6) . Since the US Surgeon General Report, many epidemiological studies with various designs have reported an association between cigarette smoking and an increased risk of cervical cancer (7, 8) . Also, assessment of a recently published IARC monograph has concluded that there is sufficient evidence for a relationship between cigarette smoking and the risk of squamous cell carcinoma of the cervix (9, 10) .
Human papillomavirus (HPV) infection is the main etiological risk factor of cervical cancer. HPV types are classified by the IARC as a cause of cervical cancer, and some HPV types are high risk for cervical cancer, others are low-risk factor (10) . There were variations in HPV prevalence and type distribution by country (11, 12) . Likewise, use of estrogen-progestogen contraceptives (oral contraceptives, OCs) is also classified by the IARC as a cause of cervical cancer, but the percentage of Japanese women whose OC use is very small in comparison with Western women (13, 14) . Hence, there is a possibility that the association between cigarette smoking and cervical cancer risk might vary in view of differences in HPV prevalence, type distribution and OC use between Japanese women and their Western counterparts.
Here, we reviewed epidemiologic studies of cigarette smoking and the risk of cervical cancer among Japanese women as a part of an ongoing research project by our group to investigate the associations between health-related lifestyle factors and site-specific cancer (15) . The findings were then summarized, and the magnitude of the effect of each lifestyle factor on cervical cancer was assessed based on previous publications targeting Japanese populations.
Methods

Search of previous study results
Details of our evaluation method have been described elsewhere (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . In brief, original data for this review were identified through searches of the MEDLINE (PubMed) and Ichushi (IgakuChuo-Zasshi) databases, complemented by manual searches of references from relevant articles where necessary. All epidemiologic studies of the association between cigarette smoking and cervical cancer incidence/mortality among Japanese women from 1950 (or 1983 for the Ichushi database) up to March 2018, including papers in press if available, were identified using the following keywords: cigarette, smoking, cervix, cervical cancer, cohort, follow-up, casecontrol, Japan and Japanese. Papers written in either English or Japanese were reviewed, and only studies of Japanese populations living in Japan were included. The individual results are summarized in the tables separately as cohort or case-control studies. For analyses of multiple publications based on the same or overlapping data sets, only data from the largest or the most recent studies were included, and for single publications describing both incidence and mortality, the former was also given priority.
Evaluation of the strength of association between cigarette smoking and cervical cancer risk Our evaluation was based on the magnitudes of association and the strength of evidence. First, the former was assessed by classifying the relative risk (RR) in each study into the following four categories, while considering statistical significance (SS) or no statistical significance (NS), as 'Strong (symbol ↓↓↓ or ↑↑↑)', <0.5 or >2.0 (SS); 'Moderate (symbol ↓↓ or ↑↑)', either (i) <0.5 or >2.0 (NS), (ii) 1.5-2.0 (SS) or (iii) 0.5-0.67 (SS); 'Weak (symbol ↓ or ↑)', either (i) 1.5-2.0 (NS), (ii) 0.5-0.67 (NS) or (iii) 0.67-1.5 (SS); or 'No association (symbol -)', 0.67-1.5 (NS). When multiple RRs were indicated in a single study, the largest RR was considered. Criteria for the magnitude of association are summarized in Table 1 . After this process, the strength of evidence was evaluated in a manner similar to that used in the WHO/FAO Expert Consultation Report, where evidence was classified as 'convincing', 'probable', 'possible' and 'insufficient' (25) . In brief, the following criteria were used-convincing: evidence based on epidemiologic studies showing consistent associations between exposure and disease, which should also be biologically plausible association; probable: evidence based on epidemiologic studies showing fairly consistent associations between exposure and disease, but with perceived shortcomings in the available evidence or some evidence to the contrary that precludes a more definite judgement; possible: evidence based mainly on findings from case-control and cross-sectional studies, requiring more studies to support the tentative associations, which should also be biologically plausible; insufficient: evidence based on findings of a 
Quantitative evaluation of associations by metaanalysis
When there was 'convincing' or 'probable' evidence of a positive or inverse association, meta-analysis was conducted to obtain summarized estimates of the association. In general, studies that had reported RRs and their confidence intervals (CIs) by comparing ever-smokers with never-smokers were included in the metaanalysis. For multiple publications of analyses using the same or overlapping data sets, only data from the largest or most updated results were included. Studies lacking information on CIs and different reference categories were excluded from the meta-analysis. General variance-based methods were used to estimate summary statistics and their 95% CIs. Heterogeneity among studies was examined by testing the Q statistic with the model used to determine summary RR and its 95% CI, i.e., a random-or fixed-effect model, selected according to the SS in the Q statistic (26) . Publication bias was assessed using funnel plot and Egger's test (27) . Meta-analysis was performed using the 'metan' and 'metabias' command of the STATA statistical package version 14 (Stata Corp LP, College Station, TX, USA). All P values were two-sided, and differences at P < 0.05 were considered statistically significant.
Results
We identified seven epidemiological studies (28-34) using the applied keywords from MEDLINE and 'Ichushi' database. After review of papers, we excluded two papers (28, 31) because the data overlapped with those used for previous study conducted by same institute. A total of two cohort studies (29, 30 ) and three casecontrol studies (32) (33) (34) were identified (Tables 2 and 3 , respectively). All of the five studies presenting RRs for cervical cancer in current smokers reported a significantly increased risk (29, 30, (32) (33) (34) . The magnitude of the increased risk was reported as strong by the three case-control studies and moderate by the two cohort studies. The three case-control studies reported the results of multivariate analysis, which presented a strong positive association between cigarette smoking and cervical cancer. A summary of the magnitude of association for the cohort studies and case-control studies is shown in Tables 4 and 5. All of the studies found a strong positive association between cigarette smoking and the risk of cervical cancer (29, 30, (32) (33) (34) . Moreover, doseresponse relationships between cigarette smoking and the risk of cervical cancer were demonstrated in two cohort studies (29, 30) and two case-control studies (32, 33) .
We then conducted a meta-analysis to clarify the magnitude of cigarette smoking among Japanese women. The summary RR for current smokers estimated by meta-analysis is presented in Fig. 1 . The RR was 1.57 (95% CI 1.28-1.86) in the cohort studies, 2.35 (1.89-2.81) in the case-control studies and 2.03 (1.49-2.57) in the studies overall. The result of meta-analysis also indicated a significantly elevated summary RR for the cohort, case-control and overall studies. Our meta-analysis showed that ever-smokers had a significantly higher risk for cervical cancer than never-smokers.
A random-effect model was selected for the meta-analysis because heterogeneity as tested by the Q statistic was high (Q = 54.2 with df = 4, P = 0.068). Although Egger's test for publication bias did not yield a significant result (P = 0.08) but had a small P value for the test. An asymmetrical shape was visually detected by the funnel plot (Fig. 2) . These findings suggested the existence of publication bias. Therefore, the summary RR of 2.03 might have been overestimated. We could not evaluate the dose-response relationship in meta-analysis because the quantitative measurement of cigarette consumption was heterogeneous across studies.
Discussion
Overall, most epidemiologic studies have consistently presented a statistically significant risk elevation for cervical cancer in smokers. Moreover, the dose-response relationships between cigarette smoking and the risk of cervix cancer risk were shown in two cohort studies and two case-control studies.
In 2006, the International Collaboration of Studies of Epidemiological Cervical Cancer (ICESCC) examined the association between smoking and the risk of cervical cancer by conducting a pooled analysis of 23 epidemiological studies, but no study has examined Japanese women. The pooled analysis reported that the RR and 95% CI for the risk of cervical cancer was 1.60 (1.48-1.73) for ever-smokers relative to non-smokers (35) . Therefore, we examined the association between smoking and the risk of cervical cancer among Japanese women. In the present study, we found that the same results in Japanese women, whose HPV prevalence, type distribution and OC use differed from those of Western women.
Although the summary RR was elevated regardless of the study design, the risk was higher for case-control studies than for cohort studies. One of the reasons why summary estimates of the association between cigarette smoking and cervical cancer risk were higher for case-control studies than for cohort studies was considered to be the difference in the study populations. In case-control studies, health-conscious people might be more likely to be selected as controls, especially when participants in health check-ups are used as controls, and patients with cervical cancer might be more likely to report their smoking histories than controls. This selection and recall bias might lead to overestimation of the association between cigarette smoking and cervical cancer risk.
Furthermore, four studies investigated the dose-response association between smoking intensity or smoking duration and risk of cervical cancer. One cohort study found a significantly increased risk of cervical cancer in subjects who smoked 20 cigarettes or more per day, and one case-control study found a significantly increased risk of cervical cancer in subjects who smoked 10 cigarettes or more per day. Hirayama et al. reported that multivariate HRs (95% CIs) for ever-smokers vs never-smokers were 1.73 (1.34-2.23) for ≤10 cigarettes/day, 1.33 (0.96-1.83) for 10-19 cigarettes/day and 2.36 (1.42-3.92) for ≥20 cigarettes/day (29) .
Also, separate analyses for smoking duration, as well as for smoking intensity, demonstrated a positive association with the risk of cervical cancer. The JACC study reported a significantly increased risk of cervical cancer in subjects who had smoked throughout the 40-year period than in those who had smoked for <40 years (30) . A case-control study conducted at Aichi Cancer Center conducted analysis stratified by age (younger, 30-44 years; middle, 45-54 years or older, 55-69 years), but the results did not change (32) . The multivariate RRs (95% CIs) for ever-smokers vs never-smokers were 2.15 (1.54-2.99) in the younger age group, 2.26 (1.38-3.70) in the middle age group and 2.38 (1.55-3.64) in the older age group. One biological mechanism is that many carcinogens in cigarette smoke might directly affect cervical cancer development. Sixteen of carcinogens in cigarette smoke are classified by the IARC as carcinogenic to humans (Group 1) (8) . Carcinogens in cigarette smoke will be conveyed to the cervical mucus and interact with the oncogenes. Prokopczyk et al. had reported that significantly higher DNA adduct levels were present in the cervix of smokers as compared with nonsmokers (36).
Other biological mechanism through which carcinogens in cigarette smoke could plausibly influence cervical cancer risk is by supporting acquisition or persistent HPV infection through impairment of immunological function. Cigarette smoking may affect innate immunity. Ferson et al. had reported that NK activities of smokers were significantly lower than that of non-smokers. Also, the levels of IgG and IgA immunoglobulin levels were significantly lower in smokers than in non-smokers (37) . Further, smoking is suspected to promote the acquisition or sustainability of HPV infection through a reduction in the number of CD4 lymphocytes, a marker of Langerhans cells and local immune responses in the vicinity of the cervix (8, 38, 39) . Therefore, cigarette smoking may be a facilitator of the association between HPV infection and cervical carcinogenesis. Results from epidemiological studies support the mechanism: the HPV Prevalence Surveys by the IARC reported that eversmoking was associated with an increased risk of being HPVpositive, even after adjustment for life-time number of sexual partner (odds ratio: 1.18, 95% CI: 1.01 − 1.39) (40) . A populationbased prospective cohort study conducted in Denmark reported that cigarette smoking may also affect an increased risk of developing high-grade squamous intraepithelial lesions among high-risk HPVpositive women (41) .
On the other hand, HPV infection might be one of the potential confounders between cigarette smoking and cervical cancer, because it is closely related to smoking habits and other high-risk sexual behaviors. Although the epidemiological evidence suggests that the majority of human cervical cancers are associated with high-risk HPV, smoking exerts an effect that is independent of HPV infection. The Surgeon General Report concluded that most studies had found that the association between cigarette smoking and the risk of squamous cell carcinoma of the cervix remained even after adjustment for HPV infection (8) . Similarly, one case-control study among Japanese women reported that the association between cigarette smoking and the risk of cervical cancer with adjusted of HPV infection (32) . As result, the RR for cervical cancer incidence in eversmokers vs never-smokers was 3.77 (95% CI: 1.08−13.18), even after adjustment by HPV infection (32) .
There were several potential limitations in the Japanese studies we reviewed. One methodological issue was assessment of smoking exposure. Information on cigarette consumption was investigated by questionnaire in all of the cohort and case-control studies. However, the definition and categorization of smoking exposure differed among the studies. The heterogeneity across studies was likely due to the different levels of cigarette consumption, which varied according to the characteristics of the study subjects, such as birth cohort, age, sex and base-population. Therefore, pooled analysis using common cigarette consumption categories is warranted. In addition, it was necessary to consider misclassification, which might have attenuated the association between cigarette smoking and the risk of cervical cancer. In spite of these methodological issues, we observed a significant association between cigarette smoking and the risk of cervical cancer, and a dose-response relationship was evident for this association. Moreover, few studies have examined information on HPV infection in the search of epidemiologic studies of the association between cigarette smoking and cervical cancer among Japanese women. However, this would have had little impact on our results, because the results of the case-control study adjusted for HPV status showed that the effect of smoking was independent of HPV infection.
Evaluation of the evidence for cigarette smoking and cervical cancer risk among Japanese women
Regarding the association between cigarette smoking and cervical cancer, although domestic research reports have been few, two large cohort studies and three case-control studies were included in this analysis, and the results are consistent with foreign reports. Also, the results were consistent with those of separate analyses for smoking intensity or smoking duration. From these results and the assumed biological plausibility, we conclude that there is convincing evidence to indicate that cigarette smoking increases the risk of cervical cancer among Japanese women. As few previous studies have made sufficient adjustment for important potential confounding factors such as passive smoking from the partner and HPV infection, the extent of any confounding effect is unclear. However, the currently available evidence suggests that these factors are unlikely to exert a strong confounding effect.
Conclusion
The existing scientific evidence is to support that cigarette smoking convincingly increases the risk of cervical cancer among Japanese women.
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